🇺🇸 FDA

Intelligence Platform

Patents

Browse 88 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8685403

Insulin-like growth factor signaling and integrin

The Regents of the University of California · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673964

Use of drug combinations for treating insulin resistance

DiaMedica Inc. · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8568713

Super fast-acting insulin compositions

HALOZYME, INC. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318154

Super fast-acting insulin compositions

HALOZYME, INC. · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8263095

Methods of use for peptides having activities of insulin like growth factor-1

CAREGEN CO., LTD. · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8168391

Method for modulating insulin production

The Regents of the University of California · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8163509

Biological markers predictive of anti-cancer response to insulin-like growth factor-1 rece

The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071323

Human monoclonal antibodies that bind human insulin like growth factors and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8034556

Regulation of glucose and insulin levels by GnT-4 glycosyltransferase activity

The Regents of the University of California · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7803940

Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin

Takeda Pharmaceutical Company Limited · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7749720

Methods of identifying compounds for producing insulin sensitization

The Regents of the University of California · Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7700128

Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxye

Takeda Pharmaceutical Company Limited · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7651845

Method and apparatus for glucose control and insulin dosing for diabetics

The Regents of the University of California · Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7629168

Insulin expressing human pancreatic islet cell line capable of reversibly proliferating an

Kuraray Medical Inc. · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622447

Use of glutathione synthesis stimulating compounds in reducing insulin resistance

DiaMedica Inc. · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7556926

Methods for screening insulin-sensitizing agents

Takeda Pharmaceutical Company Limited · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7410641

Antibodies to insulin/IGF/relaxin family polypeptides

Takeda Pharmaceutical Company Limited · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7388079

Delivery of pharmaceutical agents via the human insulin receptor

The Regents of the University of California · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7323165

Production of pancreatic islet cells and delivery of insulin

The Regents of the University of California · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7173005

Insulin and IGF-1 receptor agonists and antagonists

ANTYRA INC. · Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7056734

Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or ex

The United States of America, as represented by the Department of Health and Human Services, N.I.H. · Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7049403

Insulin/IGF/relaxin family polypeptides and DNAS thereof

Takeda Pharmaceutical Company Limited · Granted Tue May 23 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7033771

Use of insulin response modulators in the treatment of diabetes and insulin resistance

Takeda Pharmaceutical Company Limited · Granted Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6967019

Production of pancreatic islet cells and delivery of insulin

The Regents of the University of California · Granted Tue Nov 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired